Production and characterization of monoclonal and recombinant antibodies against antimicrobial Sulfamethazine

Chung-Ang University, Sŏul, Seoul, South Korea
Journal of Microbiology and Biotechnology (Impact Factor: 1.53). 05/2007; 17(4):571-8.
Source: PubMed


A monoclonal antibody (mab) against the antimicrobial sulfamethazine was prepared and characterized by an indirect competitive enzyme-linked immunosorbent assay (IC-ELISA). Sulfamethazine in the range of 0.2 and 45 ng/ml could be determined with the mab by IC-ELISA. cDNAs encoding a variable heavy chain and variable light chain of the mab were cloned to produce recombinant antibodies using phage display technology. Following phage rescue and three rounds of panning, a single-chain variable fragment (scFv) antibody with high sulfamethazine-binding affinity was obtained. ELISA analysis revealed that scFv antibody and parent mab showed similar, but not identical, characteristics. The IC50 value by IC-ELISA with scFv antibody was 4.8 ng/ml, compared with 1.6 ng/ml with the parent mab. Performances of the assays in the presence of milk matrix were compared; the mab-based assay was less affected than the scFv-based assay. Sixty milk samples were analyzed by mab-based IC-ELISA, and four samples were sulfamethazine positive; these results were favorably correlated with those obtained by HPLC.

Download full-text


Available from: Sang-Do Ha, Apr 19, 2015
  • Source
    • "ScFv is a protein sequence that is generated through the fusion of the heavy chain variable domain (V H ) and the light chain variable domain (V L ) of an antibody. A scFv is more economically produced in Escherichia coli than intact immunoglobulins, which require a high-cost mammalian cell culture system (Fernandez, 2004; Yang et al., 2007). The expression of scFv in E. coli has generally been executed in an oxidizing compartment such as the periplasmic space instead of the reducing cytoplasm of wild-type E. coli because the typical scFvs require the formation of two conserved disulfide bridges for proper folding to occur (Glockshuber et al., 1992). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Typically, single chain Fv antibodies are unable to fold properly under a reducing cytoplasm because of the reduction of disulfide bonds. The inability to fold limits both the production of the functional scFvs and their targeting against antigens, which are generally executed in a reducing cytoplasm. In this study, the target scFv CDR was grafted with stable human consensus framework sequences, which enabled the generation of a foldable scFv in a reducing cytoplasm of Escherichia coli. Additionally, the structural features affecting the folding efficiency of the engineered scFv were identified by analyzing the predicted structure. An anti-c-Met scFv, which was a cytoplasmic non-foldable protein, was redesigned as the model system. This study confirmed that the engineered anti-c-Met scFv was folded into its native form in the cytoplasm of E. coli BL21(DE3) without a significant loss in the specific binding activity against c-Met antigen. The structures of the wild-type anti-c-Met scFv and the engineered scFv were predicted using homology modeling. A comparative analysis based on the sequence and structure showed that the hydrophobicity of 12 solvent exposed residues decreased, and two newly formed salt bridges might have improved the folding efficiency of the engineered scFv under the reducing condition.
    Full-text · Article · Jun 2010 · Biotechnology and Bioengineering
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: El objetivo principal de esta tesis consiste en la obtención de anticuerpos recombinantes frente a los fungicidas azólicos tetraconazol, hexaconazol e imazalil, y su aplicación en la determinación de residuos de estos fungicidas en muestras agroalimentarias. Para ello, en primer lugar, se han aplicado técnicas de biología molecular para la obtención de los fragmentos recombinantes scFv (single chain fragment variable) a partir del material genético de hibridomas productores de anticuerpos monoclonales frente a los fungicidas tetraconazol, hexaconazol e imazalil. Posteriormente, dichos fragmentos se han expresado en sistemas bacterianos empleando vectores de expresión plasmídicos. Por otro lado, se ha optimizado un sistema de cribado y selección de colonias bacterianas productoras de fragmentos de anticuerpos recombinantes capaces de reconocer a los plaguicidas en estudio. Este sistema está basado en ELISAs simultáneos, competitivos y no competitivos, de la fracción soluble del anticuerpo recombinante. Finalmente, en el caso de los anticuerpos frente a hexaconazol e imazalil, se ha aplicado un protocolo de enriquecimiento cíclico denominado panning, basado en la tecnología de presentación de moléculas proteicas en la superficie de fagos (phage display). De este modo, se han obtenido anticuerpos recombinantes a partir de cada hibridoma productor de anticuerpos monoclonales. Cada anticuerpo recombinante se ha expresado tanto en su forma de proteína libre (scFv) como en forma de proteína de fusión (scFv-pIII). De igual modo, se han empleado técnicas de biología molecular para la generación de bibliotecas de fragmentos recombinantes scFv a partir del material genético de linfocitos de ratones inmunizados frente a cada uno de los tres fungicidas. En este caso, se han optimizado las condiciones tanto de la etapa de construcción de bibliotecas como del posterior proceso de enriquecimiento por panning.
    Full-text · Article ·
  • [Show abstract] [Hide abstract]
    ABSTRACT: A series of peptides binding to the HCV NS5B polymerase was selected from phage display peptide libraries. A conserved motif of Ser-Arg-X-Arg/Leu was identified among the selected peptides, and Pep2 (Trp-Ser-Arg-Pro-Arg- Ser-Leu) was chosen for further characterization. The binding of Pep2 to HCV NS5B in vivo was shown by a yeast twohybrid assay and by subcellular colocalization analysis using immunofluorescence confocal microscopy. The in vitro interaction was also confirmed by GST pulldown assay. The replication of the HCV 1b subgenomic replicon was efficiently inhibited by the presence of the peptide. By using a subtractive biopanning against Pep2, the binding site of the peptide was mapped at the pocket of Pro388 to Pro391 in the thumb subdomain of the polymerase. A yeast two-hybrid analysis using Pro388Ala and Pro391Ala mutants of NS5B confirmed the binding.
    No preview · Article · Mar 2008 · Journal of Microbiology and Biotechnology
Show more